Anticoagulant proves ‘promising’ in reducing dementia risk
Australian study shows AF patients on NOACs are less likely to experience cognitive decline than those on warfarin.
Tag: Pharma interest
The Pharmacy Guild says dispenser–prescriber divide is a ‘truly ancient notion’
Declaration comes as the Federal Government warns the looming north Queensland pharmacy prescribing trial is 'inconsistent' with Commonwealth medic…
mRNA vaccines scope expands beyond COVID-19
While SARS-CoV-2 vaccines have been capturing the limelight, there has also been progress in other vaccines relevant to travel medicine.
Agomelatine emerges as an option for teen depression
The first paediatric trial of the drug finds it is safe and effective for adolescents but not younger children.
Review reveals top drugs for weight loss
But the leading agents also have the most challenging profiles for adverse events, researchers say.
Omega-3 fails to make the grade for early COVID-19 therapy
Researchers report esults from a trial in 2000 Argentinian patients with early disease.
Fast-tracking drugs isn’t as helpful as it sounds
In the US four rapid approval processes have been set up to benefit patients, but the real winners seem to be Big Pharma.
Probe into death of patient on new Alzheimer’s drug
Meanwhile the sponsor has released further favourable clinical trial data.
Pelvic mesh implant appeal knocked back
The High Court of Australia's ruling means Johnson & Johnson remains liable for millions of dollars in compensation.
Study backs anti-TNFs for rheumatology patients with COVID-19
Monotherapy gave the best outcomes in an analysis of data from three registries.
